UK Markets open in 2 hrs 22 mins

Here's Why Income Investors Should Consider Buying This High-Yield Dividend Stock

·3-min read
Here's Why Income Investors Should Consider Buying This High-Yield Dividend Stock

Swiss drugmaker Novartis (NYSE: NVS) boasts a $207 billion market capitalization, which makes it the sixth-largest pharma stock in the world and the largest international-based pharma stock. Here are a few reasons income investors should consider adding this stock to their portfolios. Novartis had a decent second quarter for the period ended June 30.